Rohit Vanjani

Senior Associate

REGION United States


Rohit Vanjani is a Senior Associate at General Atlantic and focuses on investments in the Healthcare sector. Before joining General Atlantic in 2018, Rohit was a Director and Senior Analyst in Equity Research at Guggenheim Securities where he focused on specialty and generic pharmaceuticals. Prior to that, he was a Therapeutics Analyst at Pura Vida Investments, a healthcare dedicated hedge fund. Earlier in his career, Rohit was a Senior Analyst at Oppenheimer & Co, and held prior research roles at Jefferies, UBS, and Leerink Swann, covering the biotechnology, managed care, hospitals, healthcare services, and specialty pharmaceuticals verticals.


University of Michigan, B.S., Biochemistry and Economics
NYU Stern School of Business, M.B.A.